Literature DB >> 23067222

RNA-interference-mediated downregulation of Pin1 suppresses tumorigenicity of malignant melanoma A375 cells.

J Jin1, Y Zhang, Y Li, H Zhang, H Li, X Yuan, X Li, W Zhou, B Xu, C Zhang, Z Zhang, L Zhu, X Chen.   

Abstract

The peptidyl-prolyl isomerase Pin1 is overexpressed in many human cancers, including melanoma. To investigate its possible role in oncogenesis of melanoma and as a therapeutic target, we suppressed Pin1 expression in the human melanoma cell line A375 by microRNA (miRNA) interference technology. Two stable clones with suppressed Pin1 were established by stable transfection of miRNA plasmid targeting Pin1 into A375 cells. Both clones showed reduced proliferation and invasion in vitro and suppressed tumorigenic potential in athymic mice. Furthermore, Pin1 inhibition also resulted in decreased phosphorylation of Akt and repressed expression of C-Jun N-terminal kinase and pro-matrix metalloproteinase 2, which were associated closely with the development of melanoma. These findings indicate that Pin1 plays an important role in the tumorigenesis of melanoma and might serve as a promising therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23067222     DOI: 10.4149/neo_2013_013

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  7 in total

1.  AKT1E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis.

Authors:  David A Kircher; Kirby A Trombetti; Mark R Silvis; Gennie L Parkman; Grant M Fischer; Stephanie N Angel; Christopher M Stehn; Sean C Strain; Allie H Grossmann; Keith L Duffy; Kenneth M Boucher; Martin McMahon; Michael A Davies; Michelle C Mendoza; Matthew W VanBrocklin; Sheri L Holmen
Journal:  Mol Cancer Res       Date:  2019-05-28       Impact factor: 5.852

2.  Inhibition of peptidyl-prolyl isomerase (PIN1) and BRAF signaling to target melanoma.

Authors:  Christina Braun; Nadja Schneider; Dehua Pei; Anja Bosserhoff; Silke Kuphal
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

3.  Expression of peptidyl-prolyl isomerase PIN1 and its role in the pathogenesis of extrahepatic cholangiocarcinoma.

Authors:  Urangoo Jamiyandorj; Jun Sang Bae; Sang Jae Noh; Sarangerel Jachin; Ji Eun Choi; Kyu Yun Jang; Myoung Ja Chung; Myoung Jae Kang; Dong Geun Lee; Woo Sung Moon
Journal:  Oncol Lett       Date:  2013-08-12       Impact factor: 2.967

4.  Systems analysis identifies miR-29b regulation of invasiveness in melanoma.

Authors:  Miles C Andrews; Joseph Cursons; Daniel G Hurley; Matthew Anaka; Jonathan S Cebon; Andreas Behren; Edmund J Crampin
Journal:  Mol Cancer       Date:  2016-11-16       Impact factor: 27.401

5.  Prolyl isomerase PIN1 regulates the stability, transcriptional activity and oncogenic potential of BRD4.

Authors:  X Hu; S-H Dong; J Chen; X Z Zhou; R Chen; S Nair; K P Lu; L-F Chen
Journal:  Oncogene       Date:  2017-05-08       Impact factor: 9.867

6.  Standardization of A375 human melanoma models on chicken embryo chorioallantoic membrane and Balb/c nude mice.

Authors:  Stefana Avram; Dorina-Elena Coricovac; Ioana Zinuca Pavel; Iulia Pinzaru; Roxana Ghiulai; Flavia Baderca; Codruta Soica; Danina Muntean; Daciana E Branisteanu; Demetrios A Spandidos; Aristides M Tsatsakis; Cristina Adriana Dehelean
Journal:  Oncol Rep       Date:  2017-05-22       Impact factor: 3.906

7.  Cytoplasmic Pin1 expression is increased in human cutaneous melanoma and predicts poor prognosis.

Authors:  Xin Chen; Xiaosong Liu; Bin Deng; Magdalena Martinka; Youwen Zhou; Xiaopeng Lan; Yabin Cheng
Journal:  Sci Rep       Date:  2018-11-15       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.